Susan E. Waltz

4.5k total citations
114 papers, 3.3k citations indexed

About

Susan E. Waltz is a scholar working on Molecular Biology, Immunology and Hepatology. According to data from OpenAlex, Susan E. Waltz has authored 114 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 31 papers in Immunology and 29 papers in Hepatology. Recurrent topics in Susan E. Waltz's work include Liver physiology and pathology (29 papers), Axon Guidance and Neuronal Signaling (21 papers) and Wnt/β-catenin signaling in development and cancer (13 papers). Susan E. Waltz is often cited by papers focused on Liver physiology and pathology (29 papers), Axon Guidance and Neuronal Signaling (21 papers) and Wnt/β-catenin signaling in development and cancer (13 papers). Susan E. Waltz collaborates with scholars based in United States, Australia and Taiwan. Susan E. Waltz's co-authors include Belinda E. Peace, Purnima K. Wagh, Sandra J. Friezner Degen, Jerilyn K. Gray, Peterson Pathrose, Glendon M. Zinser, Mike A. Leonis, Megan N. Thobe, Alex B. Lentsch and William D. Stuart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Susan E. Waltz

110 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Waltz United States 36 1.5k 1.0k 832 817 331 114 3.3k
Ronald Hoffman United States 51 5.0k 3.2× 1.5k 1.5× 107 0.1× 1.4k 1.7× 288 0.9× 364 12.2k
Wan Yu China 27 1.7k 1.1× 308 0.3× 637 0.8× 1.2k 1.5× 100 0.3× 70 3.5k
Charles S. Abrams United States 39 2.2k 1.4× 814 0.8× 28 0.0× 362 0.4× 118 0.4× 115 4.5k
Jingsong Zhao United States 35 1.9k 1.3× 276 0.3× 62 0.1× 607 0.7× 136 0.4× 74 3.6k
William H. Sherman United States 37 931 0.6× 453 0.4× 34 0.0× 943 1.2× 422 1.3× 85 4.0k
Peter J. Richards Switzerland 27 791 0.5× 697 0.7× 22 0.0× 747 0.9× 224 0.7× 68 2.7k
Giorgio Giacomo Galli United States 16 971 0.6× 66 0.1× 239 0.3× 184 0.2× 63 0.2× 37 1.7k
Kristiina Aittomäki Finland 47 3.3k 2.1× 327 0.3× 70 0.1× 1.3k 1.6× 760 2.3× 130 7.3k
Michael Ng Hong Kong 9 864 0.6× 155 0.2× 381 0.5× 1.0k 1.2× 57 0.2× 21 1.7k
Allen Eaves Canada 37 1.3k 0.8× 696 0.7× 54 0.1× 795 1.0× 144 0.4× 102 4.6k

Countries citing papers authored by Susan E. Waltz

Since Specialization
Citations

This map shows the geographic impact of Susan E. Waltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Waltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Waltz more than expected).

Fields of papers citing papers by Susan E. Waltz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Waltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Waltz. The network helps show where Susan E. Waltz may publish in the future.

Co-authorship network of co-authors of Susan E. Waltz

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Waltz. A scholar is included among the top collaborators of Susan E. Waltz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Waltz. Susan E. Waltz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazumder, Aloran, Jonathan T. Lei, Bora Lim, et al.. (2023). Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. Science Advances. 9(26). eadf2860–eadf2860. 10 indexed citations
2.
Vicente-Muñoz, Sara, et al.. (2023). RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence. Oncogene. 42(21). 1716–1727. 10 indexed citations
3.
Benight, Nancy M., et al.. (2021). Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene. 41(3). 321–333. 15 indexed citations
4.
Benight, Nancy M., et al.. (2021). Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Letters. 503. 75–90. 13 indexed citations
5.
Krishnan, Sunil, Kathryn E. Aziz, Sarah Palackdharry, et al.. (2021). Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. Cancer Letters. 502. 180–188. 70 indexed citations
6.
Vasiliauskas, Juozas, et al.. (2020). Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression. Molecular Cancer Research. 18(8). 1244–1254. 24 indexed citations
7.
Modur, Vishnu, Navneet Singh, Vakul Mohanty, et al.. (2018). Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Nature Communications. 9(1). 4410–4410. 17 indexed citations
8.
Waltz, Susan E., et al.. (2018). Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer.. Europe PMC (PubMed Central). 1(1). 2 indexed citations
9.
Paluch, Andrew M., et al.. (2018). Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation. Neoplasia. 20(9). 917–929. 13 indexed citations
10.
Gurusamy, Devikala, et al.. (2013). Myeloid-Specific Expression of Ron Receptor Kinase Promotes Prostate Tumor Growth. Cancer Research. 73(6). 1752–1763. 45 indexed citations
11.
Benight, Nancy M. & Susan E. Waltz. (2012). Ron receptor tyrosine kinase signaling as a therapeutic target. Expert Opinion on Therapeutic Targets. 16(9). 921–931. 32 indexed citations
12.
Zhao, Huajun, Yuan-Hung Lo, Li Ma, et al.. (2011). Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth. Molecular Cancer Therapeutics. 10(1). 29–36. 76 indexed citations
13.
Wagh, Purnima K., Jerilyn K. Gray, Glendon M. Zinser, et al.. (2011). β-Catenin is required for Ron receptor-induced mammary tumorigenesis. Oncogene. 30(34). 3694–3704. 47 indexed citations
14.
Rabenau, Karen E., Dan Lu, Paul Balderes, et al.. (2006). Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Research. 66(18). 9162–9170. 105 indexed citations
15.
Leonis, Mike A., Arlene E. Dent, Meredith A. Olson, et al.. (2006). Short-form Ron receptor is required for normal IFN-γ production in concanavalin A-induced acute liver injury. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(1). G253–G261. 12 indexed citations
16.
Waltz, Susan E., Laura Eaton, Karla A. Hess, et al.. (2001). Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. Journal of Clinical Investigation. 108(4). 567–576. 5 indexed citations
17.
Peace, Belinda E., Michael Hughes, Sandra J. Friezner Degen, & Susan E. Waltz. (2001). Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene. 20(43). 6142–6151. 68 indexed citations
18.
Waltz, Susan E.. (1999). On the Universality of Human Rights. 6(3).
19.
Waltz, Susan E.. (1989). Tunisia's League and the Pursuit of Human Rights. 14. 214–225. 2 indexed citations
20.
Waltz, Susan E.. (1986). Islamist appeal in Tunisia. The Middle East Journal. 40(4). 651–670. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Hoffman Breakdown of academic impact, for papers by Wan Yu Breakdown of academic impact, for papers by Charles S. Abrams Breakdown of academic impact, for papers by Jingsong Zhao Breakdown of academic impact, for papers by William H. Sherman Breakdown of academic impact, for papers by Peter J. Richards Breakdown of academic impact, for papers by Giorgio Giacomo Galli Breakdown of academic impact, for papers by Kristiina Aittomäki Breakdown of academic impact, for papers by Michael Ng Breakdown of academic impact, for papers by Allen Eaves
Rankless by CCL
2026